Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS
· Delayed Price · Currency is USD
1.091
0.00 (0.00%)
Apr 17, 2025, 9:30 AM EDT
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of $426.66 million as of April 23, 2025. Its market cap has decreased by -21.35% in one year.
Market Cap
426.66M
Enterprise Value
355.69M
Revenue
6.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.09
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 278.91M to 426.66M, an increase of 52.98%. That is a compound annual growth rate of 12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 427.10M | -48.41% |
| Dec 31, 2024 | 827.89M | 143.75% |
| Dec 29, 2023 | 339.64M | 94.39% |
| Dec 30, 2022 | 174.72M | 26.78% |
| Dec 31, 2021 | 137.82M | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.74B |
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Elite Pharmaceuticals | 436.82M |
| Northwest Biotherapeutics | 402.62M |
| Glass House Brands | 384.26M |
| CytoDyn | 264.36M |